News & Events

News

Call for Senior Research Scientist positions

01-10-2020
Call for Senior Research Scientist positions
MIGAL Galilee Research Institute invites applicants for a Research Group Leader position in the following disciplinary areas: Organic Chemistry, Soil Chemistry, Computational/Synthetic Biology, Immunology, Plant Sciences/Health food value, Plant Genomics

The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics

01-03-2020
Biochemical Pharmacology
The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics
Patrik Prša, Betül Karademir, Gökhan Biçim, Hatem Mahmoud, Inbal Dahan, Süha Yalçın, Jamal Mahajna, Irina Milisava (2019). The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics. Biochemical Pharmacology, Volume 173.
Researchers

Initiated by UAE - First online professional symposium with Israeli CEO of the MIGAL Institute

07-09-2020
TRENDS Research and Advisory
Initiated by UAE - First online professional symposium with Israeli CEO of the MIGAL Institute

Initiated by the UAE - First online professional symposium with the participation of an Israeli, CEO of the MIGAL Institute, and other global experts to develop a COVID-19 vaccine

By Dana Elimelech

Researchers from the MIGAL Institute use the Oracle Cloud as part of their fight against COVID-19

14-09-2020
SoftNews
Researchers from the MIGAL Institute use the Oracle Cloud as part of their fight against COVID-19

The MIGAL Galilee Research Institute, which is developing a vaccine for the novel coronavirus via its subsidiary MigVax, uses the Oracle Cloud Infrastructure to support its research efforts as part of the global mobilization to combat COVID-19. As part of the development process, the researchers have been analyzing huge databases of viral genetic sequences in order to identify the virus’s weaknesses.

Researchers
Research Groups

Zebrafish help scientists speed up tests for medical cannabis strains

09-09-2020
ISRAEL 21c
Zebrafish help scientists speed up tests for medical cannabis strains
Unusual research approach speeds up discovery of which cannabis plants work best for which medical indications. Different strains of cannabis are helpful for treating different medical conditions. Testing each type for its therapeutic potential using mice or people is time-consuming.

WARNING!! Fraud Notice – Covid-19 Product

26-05-2020
Migal Galilee Research Institute Ltd., Migvax Ltd.
WARNING!! Fraud Notice – Covid-19 Product
We have just been made aware that a fake pharmaceutical product allegedly for use in connection with COVID-19 is fraudulently being advertised and apparently sold in South America with the logo of Migal and with the following wording: " COVID-19 vaccine tracker. Cutting edge Israeli Biotech innovating coronavirus immunotherapy treatments." A photograph appears below.  

Breakthrough from Israel’s MIGAL Research Institute in Development of Corona virus (COVID-19) Vaccine

27-02-2020
Israel’s Ministry of Science & Technology
Breakthrough from Israel’s MIGAL Research Institute in Development of Corona virus (COVID-19) Vaccine
After four years of research funded by Israel’s Ministry of Science & Technology, MIGAL’s researchers have developed an effective vaccine against avian coronavirus Infectious Bronchitis Virus (IBV), to be adapted soon and create a human vaccine against COVID-19 
Researchers

COVIS-19Coronavírus: vacina pode ser criada em 90 dias, diz instituto de Israel

19-03-2020
Por Márcio Juliboni
COVIS-19Coronavírus: vacina pode ser criada em 90 dias, diz instituto de Israel
Contra o tempo: cientistas israelenses afirmam estar perto de obter vacina contra o coronavírus (Imagem: Unsplash/@cdc) Uma vacina contra o coronavírus pode ser criada em 90 dias. A afirmação foi feita por David Zigdon, CEO do Galilee Research Institute (Migal), localizado na Galileia, em Israel. Zigdon participou de uma entrevista coletiva nesta quinta-feira (27), junto com sua equipe, para anunciar avanços nas pesquisas.